Literature DB >> 29300988

Nerve Biopsy Is Still Useful in Some Inherited Neuropathies.

Mathilde Duchesne1,2, Stéphane Mathis3, Laurence Richard1, Corinne Magdelaine4, Philippe Corcia5, Sonia Nouioua3, Meriem Tazir6, Laurent Magy1, Jean-Michel Vallat1.   

Abstract

In hereditary neuropathies, next-generation sequencing techniques are producing a vast number of candidate gene mutations that need to be verified or excluded by careful genotype-phenotype correlation analysis. In most cases, clinical acumen is still important but needs to be combined with data from nerve conduction studies and, in some cases, from nerve biopsy examinations. Indeed, characteristic clinical, electrophysiological, and sometimes pathological features may be suggestive of a particular subtype of Charcot-Marie-Tooth (CMT) disease. Microscopical (mainly ultrastructural) human nerve biopsy patterns may be related to CMT diseases and gene defects. Even today, it is important to recognize these characteristic lesions in the context of a chronic idiopathic neuropathy as they may help search for or reveal a sporadic form of CMT. In practice, these different types of lesions are often linked to the known function of the mutated genes. Only a few patients diagnosed or suspected as having a CMT disease need a nerve biopsy that can help find or confirm the causative gene mutation. The indication for this procedure should be based on a case-by-case discussion.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Charcot–Marie–Tooth; Genotype; Nerve biopsy; Next-generation sequencing; Phenotype; Ultrastructural

Mesh:

Substances:

Year:  2018        PMID: 29300988     DOI: 10.1093/jnen/nlx111

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  3 in total

1.  Candidate imaging biomarkers for PMP22-related inherited neuropathies.

Authors:  Alison R Roth; Jun Li; Richard D Dortch
Journal:  Ann Clin Transl Neurol       Date:  2022-06-03       Impact factor: 5.430

2.  Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls.

Authors:  Eva Placheta-Györi; Lea Maria Brandstetter; Jakob Zemann-Schälss; Sonja Wolf; Christine Radtke
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

Review 3.  Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease.

Authors:  Fukiko Kitani-Morii; Yu-Ichi Noto
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.